Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Colorcon
Johnson and Johnson
Express Scripts
Baxter

Last Updated: December 3, 2021

DrugPatentWatch Database Preview

Roche Palo Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ROCHE PALO, and what generic and branded alternatives to ROCHE PALO drugs are available?

ROCHE PALO has thirteen approved drugs.



Summary for Roche Palo
US Patents:0
Tradenames:7
Ingredients:8
NDAs:13
Patent Litigation for Roche Palo: See patent lawsuits for Roche Palo

Drugs and US Patents for Roche Palo

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche Palo FEMSTAT butoconazole nitrate CREAM;VAGINAL 019215-001 Nov 25, 1985 DISCN No No ⤷  Try it Free ⤷  Try it Free
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-002 Oct 31, 1991 DISCN No No ⤷  Try it Free ⤷  Try it Free
Roche Palo EVEX estrogens, esterified TABLET;ORAL 083376-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free
Roche Palo AEROBID flunisolide AEROSOL, METERED;INHALATION 018340-001 Aug 17, 1984 DISCN No No ⤷  Try it Free ⤷  Try it Free
Roche Palo TORADOL ketorolac tromethamine INJECTABLE;INJECTION 019698-002 Nov 30, 1989 DISCN Yes No ⤷  Try it Free ⤷  Try it Free
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-001 Mar 24, 1993 DISCN No No ⤷  Try it Free ⤷  Try it Free
Roche Palo FEMSTAT butoconazole nitrate SUPPOSITORY;VAGINAL 019359-001 Nov 25, 1985 DISCN No No ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Roche Palo

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo CYTOVENE ganciclovir CAPSULE;ORAL 020460-002 Dec 12, 1997 4,642,346 ⤷  Try it Free
Roche Palo CYTOVENE ganciclovir CAPSULE;ORAL 020460-002 Dec 12, 1997 4,355,032 ⤷  Try it Free
Roche Palo CYTOVENE ganciclovir CAPSULE;ORAL 020460-002 Dec 12, 1997 4,423,050 ⤷  Try it Free
Roche Palo CELLCEPT mycophenolate mofetil hydrochloride INJECTABLE;INJECTION 050758-001 Aug 12, 1998 5,543,408 ⤷  Try it Free
Roche Palo AEROBID flunisolide AEROSOL, METERED;INHALATION 018340-001 Aug 17, 1984 4,933,168 ⤷  Try it Free
Roche Palo CYTOVENE ganciclovir CAPSULE;ORAL 020460-002 Dec 12, 1997 4,507,305 ⤷  Try it Free
Roche Palo FEMSTAT butoconazole nitrate SUPPOSITORY;VAGINAL 019359-001 Nov 25, 1985 4,078,071 ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ROCHE PALO drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe For Oral Suspension 200 mg/mL ➤ Subscribe 2011-03-25
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Colorcon
Mallinckrodt
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.